RECRUITING

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

Description

The primary objective of this study is to evaluate the diagnostic performance of an algorithm in identifying patients with ATTR amyloidosis.

Conditions

Transthyretin Amyloidosis
Talk to us

Related Conditions:

Transthyretin Amyloidosis

Study Overview

On this page

Study Details

Study overview

The primary objective of this study is to evaluate the diagnostic performance of an algorithm in identifying patients with ATTR amyloidosis.

Evaluation of a Claims-based Algorithm for the Identification of ATTR Amyloidosis in Medical Records

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

Condition
Transthyretin Amyloidosis
Intervention / Treatment

-

Contacts and Locations

New Haven

Yale New Haven Hospital, New Haven, Connecticut, United States, 06520

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Identified by the ATTR diagnostic algorithm and matched by Yale's list of potential subjects defined as:
  • 1. subjects within the claims dataset that are predicted to be at risk of having ATTR who are also being managed within YNHHS
  • 2. patients who need to be contacted and offered additional clinical evaluation to determine whether they have a diagnosis of ATTR (non-hereditary or Hereditary ATTR amyloidosis).
  • * Patients who have opted out of research in the Epic system will be excluded entirely from the study
  • * Patients who are pregnant or who may become pregnant

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Yale University,

Edward Miller, MD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

2026-02